Uncategorized Archives - Page 38 of 65

The Authors’ Own Words: Predicting Young Adults’ Risk for Engaging in Prescription Drug Misuse in Daily Life from Individual, Partner, and Relationship Factors

Feb 10, 2020 by AMERSA

The Authors’ Own Words:

We ask authors to describe their impressions regarding the implications of their accepted work, how their findings will change practice, and what is noteworthy about the work.

Predicting Young Adults’ Risk for Engaging in Prescription Drug Misuse in Daily Life from Individual, Partner, and Relationship Factors

Lauren M. Papp, PhD & Chrystyna D. Kouros, PhD

Substance Abuse Vol. 38, Iss. 1, 2017

“Previous research has primarily relied on retrospective and global assessments to identify factors that predict which individuals are most likely to misuse prescription drugs. Our findings contribute to–and extend– this work by assessing prescription drug misuse as it occurs in daily life and multiple risk and proactive factors for misuse simultaneously. The findings indicated that females’ misuse is predicted by both individual, partner, and relationships factors, whereas males’ misuse was not predicted by any of these factors when considered together. This suggests that prescription drug misuse among young adult females is complex and preventive interventions may need to consider multiple potential targets of influence for reducing misuse. The findings also suggest that the motivating factors or triggers for prescription drug misuse may differ for males and females; thus, another practical implication of the findings is that interventions and treatments may need to be tailored differently for men compared to women to increase their effectiveness at reducing prescription drug misuse.”

The Authors’ Own Words: Public health messages about perinatal marijuana use in an evolving policy context

Feb 10, 2020 by AMERSA

The Authors’ Own Words:

We ask authors to describe their impressions regarding the implications of their accepted work, how their findings will change practice, and what is noteworthy about the work.

Public health messages about perinatal marijuana use in an evolving policy context

Marian Jarlenski, PhD, MPH; Jennifer Zank, M; Jill Tarr; & Judy C. Chang, MD, MPH

Substance Abuse Vol. 38, Iss. 1, 2017

“U.S. states are rapidly moving to legalize marijuana for medical and recreational use. For example, California, the world’s sixth largest economy, recently approved recreational marijuana use. We conducted a systematic content analysis of all U.S. state public health agency websites and 5 federal public health agency website to assess communications about perinatal marijuana use. We find that the volume of public health messages about perinatal marijuana use is low, content of messages differs across state agencies. Because the public is already being exposed to marketing messages as marijuana is commercialized, It will be important for public health agencies to develop evidence-based communications for both the lay public and health care providers. Such communications should be unbiased and regularly updated to reflect the state of the science on perinatal marijuana use.“

The Authors’ Own Words: Commitment and capacity for providing evidence-based tobacco treatment in US drug treatment facilities

Feb 9, 2020 by AMERSA

The Authors’ Own Words:

We ask authors to describe their impressions regarding the implications of their accepted work, how their findings will change practice, and what is noteworthy about the work.

Commitment and capacity for providing evidence-based tobacco treatment in US drug treatment facilities

Kimber P. Richter, PhD, MPH; Jamie J. Hunt, PhD; A. Paula Cupertino, PhD; Byron J. Gajewski, PhD; Yu Jiang, PhD; Janet Marquis, PhD; & Peter D. Friedmann, MD, MPH

Substance Abuse Vol. 38, Iss. 1, 2017

“Major changes in the funding and structure of the substance use treatment system make this an ideal time to enhance how facilities address tobacco use. In this study, the top predictor of low quality tobacco treatment was unfavorable staff attitudes toward treating tobacco dependence. This suggests that initiatives seeking integrate tobacco treatment into substance use treatment will have the greatest impact by taking a two-pronged approach targeting/changing staff attitudes and delivering the training and resources that staff need to provide high quality care.“

The Authors’ Own Words: Faculty Development Efforts to Promote Screening, Brief Intervention, and Referral to Treatment (SBIRT) in an Internal Medicine Faculty-Resident Practice

Feb 9, 2020 by AMERSA

The Authors’ Own Words:

We ask authors to describe their impressions regarding the implications of their accepted work, how their findings will change practice, and what is noteworthy about the work.

Faculty Development Efforts to Promote Screening, Brief Intervention, and Referral to Treatment (SBIRT) in an Internal Medicine Faculty-Resident Practice

Alanna Stone, MD MPH; Maria Wamsley, MD; Patricia O’Sullivan, EdD; Jason Satterfield, PhD; Derek D. Satre, PhD; & Katherine Julian, MD

Substance Abuse Vol. 38, Iss. 1, 2017

“We believe our paper has important implications both for the teaching and use of SBIRT and the implementation of future faculty development initiatives around substance abuse. SBIRT may enhance rates of screening for substance misuse, and our intervention did show an increase in reported screening by faculty. However, our intervention did not increase reported teaching of SBIRT to residents. Through qualitative interviews and a review of the literature, we suggest that targeted faculty development sessions within the clinical setting and interventions utilizing EHR may be the most effective means of engaging faculty and residents in SBIRT use.”

The Authors’ Own Words: Buprenorphine Shared Medical Appointments for the Treatment of Opioid Dependence in a Homeless Clinic

Feb 8, 2020 by AMERSA

The Authors’ Own Words:

We ask authors to describe their impressions regarding the implications of their accepted work, how their findings will change practice, and what is noteworthy about the work.

Buprenorphine Shared Medical Appointments for the Treatment of Opioid Dependence in a Homeless Clinic

Sara L. Doorley, MD; Cheryl J. Ho, MD; Elizabeth Echeverria, LCSW; Charles Preston, PhD; Huy Ngo, MD; Ahmad Kamal, MD, MSc; & Chinazo O. Cunningham, MD, MS

Substance Abuse Vol. 38, Iss. 1, 2017

“This manuscript describes a novel strategy to provide integrated, whole person care to homeless persons with opioid use disorders. The findings of this manuscript are noteworthy for the high treatment retention rates found at 12 and 24 weeks. These findings are even more noteworthy when considering the social and medical vulnerability of the individuals included in this preliminary evaluation. Furthermore, this manuscript contributes to the literature by exploring two areas of relative research paucity- buprenorphine treatment of homeless persons and office-based buprenorphine treatment using shared medical appointments. The findings of this manuscript can help guide the development of unique treatment models to serve real-world, complex patients with opioid dependence and highlights how innovation and the provision of more than usual resources can achieve health equity for vulnerable patient populations disproportionately burdened by disease.”